Forbes Medi-Tech

company

About

Forbes Medi-Tech Inc. is a life sciences company focused on evidence-based nutritional solutions. A leader in nutraceutical technology.

  • 251 - 500

Details

Last Funding Type
Series A
Last Funding Money Raised
$10.75M
Industries
Biotechnology,Dietary Supplements,Health Care,Life Science,Nutrition
Founded date
Jan 1, 1979
Number Of Employee
251 - 500
Operating Status
Active

Forbes Medi-Tech Inc. is a life sciences company focused on evidence-based nutritional solutions. A leader in nutraceutical technology, Forbes is a provider of value-added products and cholesterol-lowering ingredients for use in functional foods and dietary supplements. Forbes successfully developed and commercialized its Reducol™ plant sterol blend, which has undergone clinical trials in various matrices and has been shown to lower “LDL” cholesterol levels safely and naturally. Building upon established partnerships with leading retailers and manufacturers across the globe, Forbes helps its customers to develop private label and branded products.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$10.75M
Forbes Medi-Tech has raised a total of $10.75M in funding over 2 rounds. Their latest funding was raised on Jan 7, 2004 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 7, 2004 Series A $10.75M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Forbes Medi-Tech is funded by 1 investors. Biotechnology Development Fund VI, L.P. are the most recent investors.
Investor Name Lead Investor Funding Round
Biotechnology Development Fund VI, L.P. Series A